Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Interest Coverage Ratio (2016 - 2025)

Adma Biologics' Interest Coverage Ratio history spans 13 years, with the latest figure at 38.59 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 189.92% year-over-year to 38.59; the TTM value through Dec 2025 reached 26.93, up 169.87%, while the annual FY2025 figure was 26.93, 169.87% up from the prior year.
  • Interest Coverage Ratio reached 38.59 in Q4 2025 per ADMA's latest filing, up from 30.45 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 38.59 in Q4 2025 to a low of 4.8 in Q2 2021.
  • Average Interest Coverage Ratio over 5 years is 6.36, with a median of 0.64 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: rose 1.97% in 2021, then surged 13899.75% in 2024.
  • A 5-year view of Interest Coverage Ratio shows it stood at 3.98 in 2021, then soared by 73.45% to 1.06 in 2022, then surged by 316.84% to 2.29 in 2023, then skyrocketed by 481.25% to 13.31 in 2024, then surged by 189.92% to 38.59 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Interest Coverage Ratio are 38.59 (Q4 2025), 30.45 (Q3 2025), and 23.34 (Q2 2025).